Development of drugs for Epstein–Barr virus using high-throughput in silico virtual screening

By Li Ning   Thompson Scott   Jiang Hualiang   Lieberman Paul M   Luo Cheng  

Expert Opinion on Drug Discovery, Vol. 5, Iss. 12, 2010-12 ,pp. : 1189-1203

Informa Healthcare

Access to resources Recommend Favorite

New in silico and conventional in vitro approaches to advance HIV drug discovery and design

By Maga Giovanni   Veljkovic Nevena   Crespan Emmanuele   Spadari Silvio   Prljic Jelena   Perovic Vladimir   Glisic Sanja   Veljkovic Veljko  

Expert Opinion on Drug Discovery, Vol. 8, Iss. 1, 2013-01 ,pp. : 83-92

Informa Healthcare

Access to resources Recommend Favorite

Building a disease knowledge environment to lay the foundations for in silico drug discovery and translational medicine

By Kant Caroline S   Ibberson Mark R   Scheer Alexander  

Expert Opinion on Drug Discovery, Vol. 5, Iss. 2, 2010-02 ,pp. : 117-122

Informa Healthcare

Access to resources Recommend Favorite

Cytochrome P450 1A1-mediated anticancer drug discovery: in silico findings

By Nandekar Prajwal P   Sangamwar Abhay T  

Expert Opinion on Drug Discovery, Vol. 7, Iss. 9, 2012-09 ,pp. : 771-789

Informa Healthcare

Access to resources Recommend Favorite

In silico fragment-based drug design

By Konteatis Zenon D  

Expert Opinion on Drug Discovery, Vol. 5, Iss. 11, 2010-11 ,pp. : 1047-1065

Informa Healthcare

Access to resources Recommend Favorite